Fatty acid biosynthesis inhibitors fabimycin and triclosan trigger distinct resistance mutations in FabI and potently kill Gram-negative pathogens
Brett N. Cain, James E. Kent, Marinela L. Elane, John D Williams, Myung Rhul Lee, Gee W. Lau, Paul J. Hergenrother, Andrei L. Osterman
This study evaluates resistance profiles of E. coli to fabimycin and triclosan, showing distinct resistance mutations and minimal cross-resistance.
ACS Infectious Diseases · Aug 24, 2026Peer-reviewedMicrobiology